Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01778010 · ClinicalTrials.gov registry record · Phase 2
Modafinil for Smoked Cocaine Self-Administration
A Phase 2 study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 8
- Enrollment target
NCT01778010 is a Phase 2 study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 8 participants.
The verdict
NCT01778010, a Phase 2 study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 8 participants
- Enrollment target
Study Summary
Modafinil has been reported to reduce cocaine use in a clinical sample of infrequent users (2 days/week), but the effects of modafinil on cocaine self-administration in the laboratory have not been studied. The present study investigated the effects of modafinil maintenance on cocaine self-administration by frequent users (4 days/week) under controlled laboratory conditions. During this 48-day double-blind, crossover design study, the effects of modafinil maintenance (0, 200, and 400mg/day) on response to smoked cocaine (0, 12, 25, and 50 mg) were examined in nontreatment seeking cocaine-dependent individuals (n = 8).
Interventions
- DRUG Modafinil 0 mg
- DRUG Modafinil 200 mg
- DRUG Modafinil 400 mg
- DRUG Cocaine 0 mg
- DRUG Cocaine 12 mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2009-03 |
| Est. Completion | 2013-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01778010
The ClinicalTrials.gov registry entry for NCT01778010 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Modafinil 0 mg is the first listed.
NCT01778010 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01778010 about?
NCT01778010 is a clinical study titled "Modafinil for Smoked Cocaine Self-Administration". Modafinil has been reported to reduce cocaine use in a clinical sample of infrequent users (2 days/week), but the effects of modafinil on cocaine self-administration in the laboratory have not been studied. The present study investigated the effects of modafinil maintenance on cocaine self-administr...
What is the current status of trial NCT01778010?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2009-03. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01778010?
The interventions under investigation include: Modafinil 0 mg (DRUG), Modafinil 200 mg (DRUG), Modafinil 400 mg (DRUG), Cocaine 0 mg (DRUG), Cocaine 12 mg (DRUG).
Who is sponsoring clinical trial NCT01778010?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.